athke's cleft cysts (RCCs) are nonneoplastic epithelial lesions of the sellar and suprasellar region. They are typically asymptomatic with a slow growth rate. An asymptomatic RCC is most often diagnosed at autopsy with a reported incidence of 5%-33%. 5, [47] [48] [49] Quite often some RCCs grow over time and can become sufficiently large to cause a compressive effect on surrounding structures, resulting in neurological and endocrine abnormalities. 7, 28, 37, 42 Sixteen patients (18%) had an entirely intrasellar RCC, 21 (24%) had a purely suprasellar cyst, and 50 (58%) had an intrasuprasellar RCC. The mean cyst volume was 2.4 ± 0.9 cm 3 (range 0.36-4.9 cm 3 ). Headache was the most frequent initial symptom (76%) followed by visual disturbance (45%). The transsphenoidal approach was performed for all intrasellar RCCs (16 cysts) and 33 of 50 intrasuprasellar RCCs. The transcranial route was used for all suprasellar cysts (21 cysts) and 17 of 50 intrasuprasellar RCCs. Squamous metaplasia was present in 27 (31%) of 87 RCCs. The occurrence of squamous metaplasia was associated with cyst location (p = 0.027), T1 signal intensity (p = 0.004) and ring enhancement on Gd-enhanced MRI (p = 0.017), and cyst volume (p = 0.045). A suprasellar location (p = 0.048, OR 3.89, 95% CI 1.010-15.020), ring enhancement on Gd-enhanced MRI (p = 0.028, OR 3.922, 95% CI 1.158-13.288), hypointensity on T1-weighted MRI (p = 0.002, OR 6.86, 95% CI 1.972-23.909), and cyst volume (p = 0.01, OR 0.367, 95% CI 0.170-0.789) were independent predictors of squamous metaplasia. The mean time to reaccumulation (11 [12.6%] of 87 cases) and recurrence (7 [8%] of 87 cases) was 14 ± 6 months. Recurrence-free survival was 84.5% at a mean of 98.2 ± 4.6 months after treatment. A suprasellar cyst location (p = 0.007, OR 7.7, 95% CI 1.75-34.54), the occurrence of squamous metaplasia (p = 0.007, OR 19.3,, and isointensity on T2-weighted MRI (p = 0.041, OR 10.29, 95% CI 1.094-96.872) were the independent predictors of RCC recurrence. coNclusioNs A suprasellar cyst location, the occurrence of squamous metaplasia, and isointensity on T2-weighted MRI were independent predictors of RCC recurrence. The extent of resection and type of surgical approach used were not associated with recurrence. A tailored extent of resection based on cyst location and predictive factors is recommended.
symptoms after treatment with glucocorticoids. 32 Most often the surgically treated RCC remains stable during the long-term follow-up; however, a good number of RCCs are prone to recurrence. Numerous authors have reported their experience in the management of RCCs and have speculated about an association between recurrence and various clinical or histopathological features. 6, 18, 30, 33, 34, 39 Nonetheless, the factors that predict recurrence after surgical treatment are still debatable. 38, 54 Rathke's cleft cysts are believed to be derived from true remnants of the embryological Rathke's pouch. 3, 11, 16, 23 As regards the development of RCC, theoretically, during the 3rd or 4th week of gestation, a rostral outpouching of the ectodermal primitive oral cavity meets a downward projection from the neuroectodermal diencephalon. These structures then give rise to the anterior lobe, pars tuberalis, and pars intermedia of the pituitary gland. 3, 19, 44 The residual lumen between the anterior and intermediate lobe constitutes Rathke's cleft. The remnant of Rathke's cleft between the anterior lobe and the pars intermedia can result in an accumulation of fluid and cystic dilation leading to the purely intrasellar RCC or an intrasellar RCC with suprasellar (intrasuprasellar) extension. 44, 51 The pars tuberalis lies above the diaphragm, and the Rathke's pouch remnants in this location can give rise to an entirely suprasellar RCC. 4 Entirely suprasellar RCCs with a normal sella turcica are relatively rare (incidence 0%-20%). 8, 12, 13, 15, 20, 24, 25, 31, 36, 39 Suprasellar, intrasuprasellar, and intrasellar RCCs are distinct entities with respect to their clinical presentation, resectability, postoperative recurrence, and outcomes. Few authors have classified RCCs based on cyst location and have compared the presentations, different surgical approaches, pathological types, and surgical outcomes. 39 The present study was conducted to report clinical characteristics, histological features, and outcomes of surgically treated symptomatic RCCs. Our primary focus was to analyze the predictors of squamous metaplasia and recurrence in the 3 types of RCCs classified based on cyst location.
methods
A retrospective review of the medical records for all patients with symptomatic RCCs who had undergone resection at our institution between January 2002 and January 2012 was conducted after obtaining approval from our local ethics committee. Data points, including clinical presentation, preoperative endocrine status, operative details, imaging findings, pathology reports, and clinical outcomes, were reviewed. Preoperative pituitary function was evaluated through laboratory assessment of adrenocorticotropic hormone, growth hormone, insulin-like growth factor, prolactin levels, thyroid-stimulating hormone, thyroxin, follicle-stimulating hormone, luteinizing hormone, testosterone, and morning cortisol levels. The precise cyst location, size (calculated using the Coniglobus formula), and cyst characteristics were evaluated on Gd-enhanced T1-weighted MRI. The variation in signal intensity of the cyst on T1-and T2-weighted MRI was noted.
surgical removal
Resection is performed in all symptomatic patients with laboratory evidence of hypopituitarism, documented growth of the lesion on serial imaging, and an uncertain or alternative preoperative diagnosis. Selection of the surgical approach is based on the location of the cyst on preoperative MRI. Transsphenoidal or subfrontal, frontotemporal, and supraorbital approaches with endoscopic assistance or pure endoscopic technique were used in this study. The details of these approaches have been described in our previous publication. 13 The essential principle during resection of an RCC is to avoid manipulation of the normal pituitary gland to minimize the risk of gland injury. Complete excision of the cyst wall is attempted whenever possible. Radical resection of the cyst wall with the intention of reducing the recurrence rate was performed in 15 cases treated early in the series. For later cases in the series, the cyst contents were totally removed, and the cyst wall was partially resected to avoid transgression of surrounding structures. For cases in which no defect in the suprasellar arachnoid is identified, hydrogen peroxide is placed in the cyst cavity for 2 minutes after complete removal of the cyst contents with the intention of decimating the cyst wall lining and theoretically decreasing the proliferative ability of any residual cyst wall. The extent of resection of the cyst wall was identified based on video recordings of the surgical procedure and postoperative imaging. Specimens obtained at surgery are fixed in 10% formalin and cut into sections, and the tissues are stained with H & E. The histopathological slides are re-reviewed by a pathologist, and the cysts are classified as having or not having squamous metaplasia. An immediate postoperative MRI study is obtained within 48 hours of surgery to evaluate the extent of removal.
Follow-up
Follow-up is scheduled at 3 and 9 months after surgery and annually thereafter. Magnetic resonance imaging is performed at each follow-up visit. Pituitary function is monitored by hormone level assessment at 1, 3, 6, and 12 months after surgery. Recurrence was defined as the reaccumulation of cyst contents on follow-up imaging with or without symptomatic recurrence.
statistical analysis
The mean ± standard deviation, median, and range for continuous variables and the frequency for discrete data were calculated for patient demographics. Univariate analysis using the chi-square test for categorical variables and the Mann-Whitney U-test or Kruskal-Wallis test for continuous variables was performed to evaluate the association of clinical parameters with the location of the RCC, the occurrence of squamous metaplasia, and recurrence. Multivariable binary logistic regression analysis was conducted to evaluate the predictors of squamous metaplasia. The Hosmer-Lemeshow statistic was used to assess the fit of the models. Kaplan-Meier analyses with the log-rank model were used to evaluate recurrence-free survival (RFS). Multivariable stepwise Cox proportional-hazards regression analysis was used to identify independent predictors of recurrence. All variables with a p value ≤ 0.05 in the univariate analysis, in addition to age at the time of surgery and histology, were included as independent variables. All the analyses were tested at the 0.05 level of significance, and the analysis was performed using the SPSS version 20 (IBM Inc.).
results
The mean age of the 87 patients eligible for this study was 41 ± 14 years (range 10-73 years). There were 64 female (74%) and 23 male (26%) patients. Among the entire population, 16 patients (18%) had an entirely intrasellar RCC (Fig. 1) , 50 (58%) had an intrasuprasellar cyst (Fig.  2) , and 21 (24%) had a purely suprasellar lesion ( Fig. 3 and Table 1 ). The mean cyst volume was 2.4 ± 0.9 cm 3 (range 0.36-4.9 cm 3 ).
preoperative Findings
Headache was the most frequent initial symptom, occurring in 66 cases (76%). Visual disturbance was reported in 39 patients (45%). Preoperative hyperprolactinemia, hypopituitarism, and diabetes insipidus (DI) were found in 31 (36%), 29 (33%), and 17 (20%) patients, respectively. Thirty-one patients had more than 1 of these presenting symptoms. The incidence of preoperative symptoms was not significantly associated with recurrence. The incidence of hyperprolactinemia was significantly higher in patients with the intrasellar type of cyst (p = 0.005). In 29 patients with hypopituitarism, hypocortisolism was the most common dysfunction (24%), followed by hypothyroidism (20%), hypogonadism (15%), and growth hormone deficiency (10%). Fourteen patients had hormonal deficiency in 2 or more hormonal axes. The mean duration of preoperative symptoms was 17 ± 23 months (range 1-108 months). The RCCs demonstrated variable signal intensity on T1-and T2-weighted MRI (Tables 1 and 2 ).
surgical details
The transsphenoidal approach was used for all intrasellar RCCs (16 cases) and the intrasuprasellar RCCs with only a thin portion of or no pituitary gland occupying the sellar floor (33 cases; Table 1 ). The transcranial route was used to access purely suprasellar cysts (21 cases) and intrasuprasellar cysts with gland covering a major part or most of the sellar floor (17 cases). Traditional craniotomies were performed in 18 cases treated between 2002 and 2006. Since 2006, a supraorbital keyhole approach was used (17 cases); traditional craniotomies were only used for 3 lesions with an uncertain preoperative diagnosis or in those cases in which the residual pituitary gland was displaced inferiorly, which could block the trajectory via the endonasal approach. 13 Fifteen patients had complete excision of the cyst wall; 6 patients (40%) developed new hypopituitarism postoperatively. Complications resulting from surgery included CSF leakage, infection, new-onset hypopituitarism, and DI (Table 1) . Postoperative CSF leakage occurred in 3.4% of patients (3 of 87), all of whom had undergone endonasal surgery; the leak resolved with bed rest and/or lumbar drainage in all of the patients. Five patients (6%) experienced new DI, whether temporary or permanent; there was no significant difference in the occurrence of DI among the 3 cyst groups (p = 0.47). Permanent DI occurred in only 1 patient. The postoperative infection rate (8 [9%] of 87 patients) was associated with squamous metaplasia (p = 0.04).
squamous metaplasia
Squamous metaplasia was present in 27 (31%) of 87 RCCs: 2 (13%), 14 (28%), and 11 (52%) cases were intrasellar, intrasuprasellar, and suprasellar, respectively ( Table  1 ). The occurrence of squamous metaplasia was associated with cyst location (p = 0.027), T1 signal intensity (p = 0.004) and ring enhancement on Gd-enhanced MRI (p = 0.017), and cyst volume (p = 0.045). In multivariable logistic regression analysis, a suprasellar location (p 
Follow-up and outcomes
The mean duration of follow-up was 54 ± 29 months (median 60 months, range 9-131 months). Preoperative headaches improved in 56 (85%) of 66 patients. There was a significant difference in the rate of postoperative headache improvement among the RCC types; the rate of improvement was highest in the intrasellar type (92%) and lowest in the suprasellar (66%; p = 0.03). Of the 39 patients presenting with visual dysfunction, 37 (94%) experienced an improvement following surgery. Hyperprolactinemia improved remarkably in 29 (94%) of 31 patients. In contrast, hypopituitarism resolved in only 16 (55%) of 29 patients, and DI in 11 (65%) of 17 patients. There was a significant difference in the rate of postoperative improvement in hypopituitarism among the RCC types; all but 1 patient in the intrasellar group improved (86%), whereas only 29% of patients in the suprasellar group improved (p = 0.02). Hypocortisolism and hypogonadism resolved in 62% and 54% of patients, respectively. Growth hormone deficiency and hypothyroidism resolved in only 33% and 35% of patients, respectively. Eight patients (9.2%) had new hypopituitarism, and 5 patients (5.7%) had new DI after cyst evacuation/resection. New postoperative hypopituitarism was encountered in 1 patient with a suprasellar RCC, 2 with intrasellar RCC, and 5 with intrasuprasellar RCC. There was no significant difference in the occurrence of new postoperative hypopituitarism among the 3 types of RCC.
recurrence
The mean time to recurrence was 14 ± 6 months. Eleven patients (12.6%) had MRI evidence of the reaccumulation of cyst fluid; 7 (63.6%) of these 11 patients had symptomatic recurrence. All but 1 recurrent case demonstrated homogeneous isointensity on T2-weighted MRI. Two patients underwent a traditional craniotomy for cyst recurrence, and the other 5 patients underwent repeat endonasal surgery. The recurrent RCCs were treated based on the same principles as the primary cases. Aggressive complete resection of the cyst wall was attempted in all recurrent cases. No new deficits were noted in any pa- (Table 3) . Recurrence-free survival was 84.5% at a mean of 98.2 ± 4.6 months after treatment (Fig. 5) . The RFS for intrasellar, intrasuprasellar, and suprasellar RCCs was 100%, 90% (105.33 ± 4.3 months), and 71.4% (78.1 ± 11 months), respectively. The difference in RFS among the RCC types was significant (log-rank/Mantel-Cox, l 2 = 7.8, p = 0.005). Recurrence-free survival for patients with squamous metaplasia was 60% (65.2 ± 6.8 months). There was a significant difference in RFS among the RCC types with and without squamous metaplasia (log-rank/Mantel-Cox, l 2 = 20.2, p < 0.0001). Recurrence-free survival for the intrasuprasellar cyst type with squamous metaplasia was 64.3%, mean 74.3 ± 7.8 months, and that for the suprasellar cyst with squamous metaplasia was 54.5%, mean 44.6 ± 6.4 months (log-rank/Mantel-Cox, l 2 = 24.9, p < 0.0001).
discussion
The rate of recurrence after surgical evacuation of an RCC has been reported to be in the range of 0%-42% at a mean follow-up of 5 years. 1, 13, 18, 26, 31, 33, 38, 39, 45, 51 Symptomatic recurrence has been reported in up to 57% of the patients with radiological evidence of recurrence. Table 4 features a summary of published studies on recurrence in surgically treated symptomatic RCCs. The rate of recurrence in the present study was 12.6% at a median of 5 years' follow-up. A suprasellar cyst location, squamous metaplasia, and isointensity on T2-weighted MRI were the independent predictors of cyst recurrence.
cyst location
A suprasellar cyst location was an independent predictor of squamous metaplasia and recurrence. The rate of recurrence increased by 17% (from 45.5% to 28.6%) in suprasellar cysts with squamous metaplasia, as compared with those without squamous metaplasia. There was a significant association between a suprasellar RCC and a smaller cyst volume (< 2.5 cm RCC was not associated with recurrence; 28% of patients with intrasuprasellar RCCs had squamous metaplasia.
squamous metaplasia
A suprasellar cyst location, ring enhancement on Gdenhanced MRI, hypointensity on T1-weighted MRI, and increased cyst volume were the independent predictors of squamous metaplasia. These preoperative parameters can be used to identify the occurrence of squamous metaplasia, which is an independent predictor of recurrence. Several theories have been proposed to account for the association between squamous metaplasia and recurrence. 6, 18, 21, 22, 26, 28, 34, 5153 One theory is that the RCC and craniopharyngioma are part of the same disease spectrum, and the transition from single cuboidal epithelium to squamous epithelium represents the type of RCCs that may be a close continuation of craniopharyngioma. The presence of squamous metaplasia makes the distinction between a papillary craniopharyngioma and an RCC difficult. 18, 27, 31, 33, 35, 40, 52 In the present study, 4 of the 11 recurrent cases demonstrated a tumor-like appearance of the cyst on preoperative MRI; however, the histopathology revealed RCCs with squamous metaplasia (Fig. 4D) . Similar findings in anecdotal cases have been reported in the literature. 35, 46 Papillary craniopharyngiomas are more solid, unlike RCCs, which demonstrate the presence of extensive ciliation with mucin production. Another theory for squamous metaplasia in RCC is that chronic inflammation may lead to metaplastic transformation from cuboidal and columnar to squamous epithelium. In a series of 151 RCCs, the authors reported no significant association between recurrence and squamous metaplasia or reactive inflammation. 39 In the present study, intraoperative inflammation was present in 13 (48%) of 27 cases with squamous metaplasia. Inflammation in the cyst wall can appear as ring enhancement on preoperative MRI. We found that ring enhancement was present in 81% of the cases with squamous metaplasia and was an independent predictor of squamous metaplasia. An increased cyst volume predicted the occurrence of squamous metaplasia in the cyst wall. A large RCC may represent chronic growth of the cyst, which may predispose the cyst wall to inflammation and metaplastic transformation.
magnetic resonance imaging
The variable signal intensity on preoperative MRI has been associated with the number and type of secretory cells, the presence or absence of chronic inflammation, and the rate of cell desquamation. 50 As previously demonstrated, hypointensity on T1-weighted MRI and ring enhancement on Gd-enhanced T1-weighted MRI were independent predictors of squamous metaplasia. The peripheral rim enhancement has been attributed to changes due to squamous metaplasia, inflammation, a circumscribed area of pituitary tissue peripheral to the cyst wall, or deposition of hemosiderin or cholesterol crystals in the cyst wall. 3 Most of the recurrent cases (10 of 11) demonstrated isointensity on T2-weighted MRI, which was an independent predictor of recurrence in our study.
cyst resection
Surgical treatment frequently provides relief of head- aches and visual disturbances, and sometimes even improves endocrine dysfunction. The surgical treatment of RCC has evolved with advances in techniques and a better understanding of the cyst's natural history. Traditionally, transcranial approaches were used with complete excision of the cyst and cyst wall fenestration. Radical resection of the cyst wall was performed in 15 of our early cases with the intention of reducing the recurrence rate. 10, 26 Later on in our series, cyst evacuation, along with partial resection of the cyst wall that did not adhere to the pituitary gland, was performed. 11, 22, 51 For recurrent RCCs, studies have recommended aggressive removal of cyst wall in the suprasellar cistern to allow communication between the cyst and CSF spaces followed by postoperative irradiation. 33 None of the cases in the present study received postoperative radiation. Few authors have reported a significant association between the extent of cyst resection and recurrence. 18, 26 In present study, however, we observed no association between the extent of resection and recurrence. A higher incidence of postoperative hypopituitarism and CSF leakage is associated with the aggressive resection of predominantly intrasellar RCCs. 41 Aggressive resection of the cyst wall may not be necessary in intrasellar RCCs given that there were no cases of recurrence in this group with and without squamous metaplasia. For purely suprasellar RCCs, aggressive resection of the cyst wall may be reasonable, as the suprasellar location was an independent predictor of squamous metaplasia and recurrence. In a review of the literature, a microsurgical transsphenoidal approach was found to have a higher rate of recurrence (14% vs 8%) and new endocrine dysfunction (25% vs 10%) compared to the endoscopic approach. 30 In the present study, the surgical approach used significantly differed among the different types of RCC; for example, suprasellar RCCs were resected via the transcranial pterional/subfrontal approach or supraorbital keyhole craniotomy. For most intrasuprasellar RCCs and for all intrasellar RCCs, an endonasal transsphenoidal approach was optimal. But for a few intrasuprasellar RCCs with a large volume (> 3 cm 3 ) or for those with primary suprasellar extension, the transcranial approach allowed better resection without transgression of the pituitary. The extent of resection and recurrence were not associated with the type of surgical approach performed.
study limitations
Despite the contributions that this study makes to the literature, it has several notable limitations. It is a singlecenter experience, and thus bears all the limitations associated with a retrospective study design. The number of patients in each RCC type is relatively small. Additional studies with a multicenter prospective design and a larger number of patients with each RCC type may provide more robust data for an analysis of predictors of squamous metaplasia and recurrence.
conclusions
A suprasellar cyst location, ring enhancement on Gdenhanced MRI, hypointensity on T1-weighted MRI, and cyst volume were the independent predictors of squamous metaplasia. A suprasellar cyst location, the occurrence of squamous metaplasia, and isointensity on T2-weighted MRI were the independent predictors of RCC recurrence. The extent of resection and type of surgical approach used was not associated with recurrence. Aggressive resection may be reasonable in recurrent cases. A tailored extent of resection based on cyst location and predictive factors is recommended.
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